SiteOne Therapeutics Gets Investment Round

Bozeman, Montana-based SiteOne Therapeutics said last week that it has received a round of funding, from local investor Next Frontier Capital. Size of the investment round was not announced. SiteOne said the funding also included 2M Companies Inc., Sears Capital Management, Biobrit LLC, Mission Bay Capital and Z Investments. Next Frontier's Will Price joins SiteOne's board as part of the funding. Next Frontier is also based in Bozeman. SiteOne is developing treatments for acute and chronic pain, based on sodium ion channel inhibitors developed originally at Stanford University. More information »